Index of artpub/2022/282310/

Lindskog, M
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma : A Randomized Phase 2 Study
2022
https://ddd.uab.cat/record/282310